TABLE 3.
A, Associations with overall survival and clinicopathologic characteristics in TCGA patients using Cox regression. B, Multivariate survival model after variable selection
| Clinicopathologic variable | HR | HR.95L | HR.95H | p‐value |
|---|---|---|---|---|
| (A) | ||||
| Age | 1.00 | 0.98 | 1.02 | 0.929 |
| Gender | 1.00 | 0.70 | 1.43 | 0.996 |
| Stage | 1.64 | 1.40 | 1.94 | <0.001 |
| T | 1.62 | 1.31 | 2.01 | <0.001 |
| M | 1.68 | 0.92 | 3.06 | 0.089 |
| N | 1.79 | 1.46 | 2.19 | <0.001 |
| NUP62CL | 1.49 | 1.18 | 1.87 | 0.001 |
| (B) | ||||
| Stage | 2.07 | 1.30 | 3.31 | 0.002 |
| T | 1.13 | 0.88 | 1.44 | 0.333 |
| N | 0.95 | 0.64 | 1.42 | 0.806 |
| NUP62CL | 1.40 | 1.09 | 1.80 | 0.008 |
Abbreviations: M, metastasis; N, node; T, tumor.